search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
INFECTION PREVENTION


ELEVATE YOUR STANDARD OF CARE


tions, on SSIs, dehiscence, and length of hospital stay in comparison to standard of care.” Zagger noted that the meta-analysis3


calculated


“overall number of high-risk patients needed to treat (NNT) with PICO sNPWT to prevent one costly and potentially dangerous and painful SSI was just 14; this was further reduced to an T of fi ve for patients un- dergoing colorectal surgery. This underlines the impor- tance of adopting the use of this advanced and novel innovation to help treat our patients with confi - dence and lower the potential incidence for post-surgical complications.” DERMATAC Drape is a new, single-use, pro- prietary silicone- acrylic hybrid drape used as an


Smith & Nephew's PICO Single Use Negative Pressure Wound Therapy System


accessory to vacuum-assisted closure therapy. onald ilverman, M, A, hief Medical ffi cer, , said, “NPWT dressing applications can be cumbersome, time- consuming for clinicians, and sometimes painful for patients. We sought to address these challenges by re-engineering drape design and chemistry, leading to the introduction of DERMA- TAC Drape, which adapts to body contours and is strong enough to maintain a seal for up to 72 hours, yet is gentle at removal. t has operational benefi ts for clinicians, such as the ability to reposition the drape during initial application and dressing changes without losing adhesion, and it is easier to use across multiple wound types.”


PROVEN to Deliver Savings:


• Reduces expenses related to staff injuries by 50-100%


• Streamlines product use - one product for transfers and positioning


• Verified compatibility with low air-loss beds • Reprocessable to meet your green initiatives


Silverman continued, “In a limited commercial release across twenty-one U.S. centers and approximately 350 patients in acute and post-acute facilities, DERMATAC Drape held a seal for 72 hours. A majority of the patients who received DERMATAC rape agreed it was painless upon removal, and eighty-fi ve percent of clinicians said DERMATAC Drape was easier to use and faster to apply than traditional drapes. Patients may remain on NPWT longer, or behave more compliantly with


www.HoverMatt.com Visit www.ksrleads.com/?909hp-014 28 September 2019 • HEALTHCARE PURCHASING NEWS • hpnonline.com DERMATAC Drape, from KCI


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56